BioAsia, Asia’s technology and bio-business platform for biotechnology and life sciences announced that Spain will be the Country Partner and GVK Biosciences will be the principal industry sponsor for the 10th edition of BioAsia – BioAsia 2013. Taking place at the Hyderabad International Convention Centre (HICC), Hyderabad from January 28 to 30, the life sciences dynamic global forum will witness convergence under its cutting-edge theme of Technologies Business Next. BioAsia 2013, hosted by Government of Andhra Pradesh with the support FABA and Pharmexcil, is going to be the window to the future of lifesciences.
BioAsia 2013 has also joined hands with Victoria (Australia) which is the international state partner for the event this year. These country and state level partnerships will open up and enhance the bilateral trade in these regions in addition to fostering scientific and technological collaborations. The 10th edition of this leading industry event has also received tremendous response from the industry with Natco, Lonza, Mayar Biotech joining as the industry co-host.
The principal industry host is GVK Biosciences, industry co-hosts are Natco Pharma, Bharat Biotech, Lonza, Mayar Biotech; corporate sponsors are IKS International (Netherlands), Canara Bank; session sponsor is – GE Healthcare; logistic partner is Sequel Logistics; State partners are Karnataka and Madhya Pradesh; partners are APIIC, FICCI and knowledge partner is Grant Thornton.
Department of Biotechnology; Department of Pharmaceuticals; Indian Council of Medical Research; Defense Research & Development Organisation (DRDO) from the Government of India have joined hands with BioAsia 2013 like each year. Commenting on the event S Raghavan, Joint Secretary, Department of Biotechnology, GoI – the apex body for Biotechnology in the country said, “BioAsia is playing an important role in mobilising investments into the biotechnology arena of the country. It has emerged as a prominent platform for facilitating investments, exploring technology opportunities as well as research and innovations for the sector. Dept of Biotechnology is happy to support this global event. The 10th edition of BioAsia has attracted a wider participation from across the industry that will culminate into more holistic discussion, debate and decision making giving the much needed momentum to the growth of the biotech industry.”
Commenting on the developments, Shakthi M Nagappan, Chief Executive Officer, BioAsia, said, “We are delighted with the response from various regions and industry stalwarts like to be part of BioAsia 2013. Our partners, sponsors and participants have recognised the incremental value that BioAsia has added to the industry and we are confident to carry forward the momentum with our 10th edition which is all set to bring excellent opportunities to network with potential business prospects across geographies and deliberate on the growth drivers of future.”
Commenting on the continued partnership with BioAsia, Manni Kantipudi, Chief Executive Officer, GVK Biosciences said, “I have seen BioAsia grow year-over-year for the last five years. It has evolved to be one of the top conferences in India for bio-pharmaceutical companies and offers a good platform for industry/Government interaction. Today, BioAsia has a global reach and has participants from over 50 countries. GVK BIO is pleased to be the principal sponsors for BioAsia 2013.”
Dr AKS Bhujangara Rao, President (R&D), Natco Pharma said, “Bio-Asia has been the ‘mouth- piece’ of the Indian life sciences activities bridging state-of-the-art academic inventions the industry’s emerging capabilities and the societal health care needs. The Indian bio-pharma industry is grateful to Bio-Asia for its initiatives over the years.”
“BioAsia provides the perfect platform to target the right persons at the right level. We are pleased to partner with BioAsia and believe that it is a forum to launch and create visibility for our Indian subsidiary,” said Vikas Bhargava, Director (India Operations), IKS International.
“BioAsia as a platform has been evolving consistently each year adding new dimensions to spur the expansion of the industry with the growing global participation. We see a great potential in this event as it has and continue to help biopharma and life sciences industry to prosper and grow to new heights,” said Deepak Sood, Business Director – South Asia & Middle East, Lonza Biosciences.
EP News Bureau – Mumbai